Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults

Table 5 The profile of MetS components in women aged 45 to 65 of different high density lipoprotein group at baseline (n = 1 088)

Variable	High-normal HDL (n = 625)			Normal HDL (n = 413)			Low HDL (n = 50)
Variable	Baseline	Follow-up	P-value	Baseline	Follow-up	P-value	Baseline	Follow-up	P-value
HDL (mmol/L)	1.76 ± 0.22	1.69 ± 0.32	<0.0001	1.28 ± 0.14	1.46 ± 0.29	0.0003	0.98 ± 0.11	1.58 ± 0.27	<0.0001
SBP (mmHg)	111.88 ± 9.68	116.32 ± 15.01	<0.0001	111.90 ± 8.98	118.10 ± 15.19	<0.0001	111.92 ± 9.08	119.96 ± 14.08	<0.0001
DBP (mmHg)	74.14 ± 6.36	71.52 ± 9.77	0.9928	74.64 ± 6.21	72.79 ± 9.66	0.0064	74.04 ± 6.62	72.86 ± 10.70	0.9747
TG (mmol/L)	1.01 ± 0.34	1.14 ± 0.57	<0.0001	1.11 ± 0.30	1.21 ± 0.53	<0.0001	1.14 ± 0.37	1.24 ± 0.58	<0.0001
FPG (mmol/L)	4.97 ± 0.38	5.10 ± 0.46	<0.0001	4.95 ± 0.39	5.16 ± 0.50	<0.0001	4.70 ± 0.52	5.19 ± 0.49	<0.0001
BMI (kg/m2)	23.18 ± 2.52	22.95 ± 2.76	<0.0001	23.96 ± 2.27	23.34 ± 2.49	0.0008	24.29 ± 2.17	23.50 ± 2.79	0.9406

HDL high density lipoprotein, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, FPG fasting plasma glucose.
BMI body mass index. P-value is based on paired t-test.

ISSN: 1471-2458